BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dwyer Z, Chaiquin M, Landrigan J, Ayoub K, Shail P, Rocha J, Childers CL, Storey KB, Philpott DJ, Sun H, Hayley S. The impact of dextran sodium sulphate and probiotic pre-treatment in a murine model of Parkinson's disease. J Neuroinflammation 2021;18:20. [PMID: 33422110 DOI: 10.1186/s12974-020-02062-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Li Y, Chen Y, Jiang L, Zhang J, Tong X, Chen D, Le W. Intestinal Inflammation and Parkinson's Disease. Aging Dis 2021;12:2052-68. [PMID: 34881085 DOI: 10.14336/AD.2021.0418] [Reference Citation Analysis]
2 Klann EM, Dissanayake U, Gurrala A, Farrer M, Shukla AW, Ramirez-zamora A, Mai V, Vedam-mai V. The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review. Front Aging Neurosci 2022;13:782082. [DOI: 10.3389/fnagi.2021.782082] [Reference Citation Analysis]
3 Jackson A, Engen PA, Forsyth CB, Shaikh M, Naqib A, Wilber S, Frausto DM, Raeisi S, Green SJ, Bradaric BD, Persons AL, Voigt RM, Keshavarzian A. Intestinal Barrier Dysfunction in the Absence of Systemic Inflammation Fails to Exacerbate Motor Dysfunction and Brain Pathology in a Mouse Model of Parkinson's Disease. Front Neurol 2022;13:882628. [DOI: 10.3389/fneur.2022.882628] [Reference Citation Analysis]
4 Fenner BM, Fenner ME, Prowse N, Hayley SP. LRRK2 and WAVE2 regulate microglial-transition through distinct morphological phenotypes to induce neurotoxicity in a novel two-hit in vitro model of neurodegeneration. J Cell Physiol 2021. [PMID: 34543438 DOI: 10.1002/jcp.30588] [Reference Citation Analysis]
5 Sun JN, Yu XY, Hou B, Ai M, Qi MT, Ma XY, Cai MJ, Gao M, Cai WW, Ni LL, Xu F, Zhou YT, Qiu LY. Vaccarin enhances intestinal barrier function in type 2 diabetic mice. Eur J Pharmacol 2021;908:174375. [PMID: 34303666 DOI: 10.1016/j.ejphar.2021.174375] [Reference Citation Analysis]
6 Leta V, Ray Chaudhuri K, Milner O, Chung-Faye G, Metta V, Pariante CM, Borsini A. Neurogenic and anti-inflammatory effects of probiotics in Parkinson's disease: A systematic review of preclinical and clinical evidence. Brain Behav Immun 2021;98:59-73. [PMID: 34364965 DOI: 10.1016/j.bbi.2021.07.026] [Reference Citation Analysis]
7 Van Den Berge N, Ulusoy A. Animal models of brain-first and body-first Parkinson's disease. Neurobiology of Disease 2022;163:105599. [DOI: 10.1016/j.nbd.2021.105599] [Reference Citation Analysis]